KLF4 can restrain the migration and proliferation of cancer cells by inhibiting downstream molecules of WNT signaling, such as cyclinD1 and c-Myc (48), and directly regulating the WNT/β-catenin pathway to inhibit EMT (49). The gene discussed is KLF4; the disease is cancer.